Research Peptides

Retatrutide is a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors. Research explores multimodal metabolic regulation. Lyophilized. COA included. For laboratory research use only. Not for human consumption.

Retatrutide is a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors. High-dose vial. Lyophilized. COA included. For laboratory research use only. Not for human consumption.

Cagrilintide is a long-acting amylin analogue. Research investigates satiety regulation and metabolic homeostasis. Lyophilized. COA included. For laboratory research use only. Not for human consumption.

Liraglutide is a GLP-1 receptor agonist with extended half-life via fatty acid modification. Research focuses on metabolic and cardiovascular effects. Lyophilized. COA included. For laboratory research use only. Not for human consumption.

Semaglutide is a GLP-1 receptor agonist. High-dose vial. Lyophilized. COA included. For laboratory research use only. Not for human consumption.

Semaglutide is a GLP-1 receptor agonist. Research focuses on glucose regulation and appetite suppression pathways. Lyophilized. COA included. For laboratory research use only. Not for human consumption.

Tirzepatide is a dual GIP and GLP-1 receptor agonist. High-dose vial. Lyophilized. COA included. For laboratory research use only. Not for human consumption.

Tirzepatide is a dual GIP and GLP-1 receptor agonist. Research investigates combined incretin effects on metabolic pathways. Lyophilized. COA included. For laboratory research use only. Not for human consumption.